More than 30 academia and industry leaders spoke at the conference
Potomac, Maryland (PRWEB) June 25, 2010
The Chinese Biopharmaceutical Association-USA (CBA) successfully held its 15th Annual Conference on June 12 -13 at USM Shady Grove Center, Rockville, Maryland.
With the theme of Biopharmaceutical Medicines: Development and Commercialization without Borders, the two-day conference drew near 500 global attendees including research scientists, entrepreneurs, representatives from government agencies, and investors.
More than 30 academia and industry leaders spoke at the conference. Five delegations from China’s leading biotech parks sponsored and presented at the conference, . including presentations from Mr. Guang-Yuan Liu, Mister of the Embassy of the People's Republic of China in the USA, and Mr. John P. McDonough, Secretary of the State of Maryland, attended the conference and delivered opening remarks.
Dr. Sujuan Ba, president of CBA president (2010-2011) and Chairperson of the cConference, presented the 2010 CBA Brilliant Achievement Award to Dr. Eric Green, director of the National Human Genome Research Institute, National Institutes of Health, and Mr. Gabriel Leung, president of Pharmaceuticals Business, OSI Pharmaceuticals.
The CBA Brilliant Achievement Award was established in 2003 to honor outstanding individuals who have made seminal contributions to science, technology, or business development in the biopharmaceutical fields; whose vision has moved medicine in new directions; and, who has been actively involved in building collaborative efforts internationally to advance medical fields.
The Award also aims to promote public awareness of the importance of collaborations between basic and applied researchers, between academia and industry, and between researchers and entrepreneurs.
Dr. Sujuan Ba also presented the 2010 CBA Outstanding Public Serviced Award to former CBA President (2004-2005) Dajun Yang, MD, PhD, President and CEO of Ascentage Pharma Group Corp., in reorganization of his long-lasting devotion to the growth of the CBA and his relentless efforts to help fulfill CBA’s mission of facilitating collaboration between biopharmaceutical professionals and promoting global business collaboration in biopharmaceutical fields.
At the end of the conference, Dr. Longzhi Feng was elected CBA’s new president-elect (2010-2011). According to CBA’s bylaw, Dr. Sujuan Ba automatically became CBA’s president and Dr. Yifan Zhai become CBA’s immediate-past president. He encourages every one of the CBA members to have a sense of ownership between the whole organization is “one body.”
About the Chinese Biopharmaceutical Association - USA
The Chinese Biopharmaceutical Association – USA (CBA) is one of the largest Chinese American professional associations in the United States. Founded in 1995, CBA is an independent, non-political, not for-profit professional organization dedicated to promoting science, technology, and business development in the biopharmaceutical fields by fostering research and business collaborations around the world. The Association is led by its elected board of directors and executive committee. For more information about the CBA and its programs, visit http://www.cba-usa.org.